Regulators move the goalposts for a manufacturer that uses mRNA technology.

In December, the Centers for Medicare and Medicaid Services announced an end to state vaccine reporting requirements, ...

The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu ...

Senior FDA official Vinay Prasad reportedly overrode his staff in deciding to reject Moderna's application for a new seasonal flu shot.

Federal officials on Wednesday cast blame on Moderna as they stood by the Food and Drug Administration’s controversial ...

It is our duty as health care professionals to work across medicine, science and public health to make sure the U.S. has a ...

The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with mRNA ...

In this week’s edition of InnovationRx, we look at the healthcare giants on Forbes new Greatest Innovators list, why Garner ...

Moderna stock is rated Sell amid FDA setbacks for mRNA-1010, commoditized COVID/RSV sales, and cash burn. Read the analysis ...

In the early 1960s, after studies confirmed that it was linked to congenital disorders in more than 10,000 children, ...

Company Expects to Report Topline Data from OPUS-3 Trial and OPUS-2 Phase 3 Trial Evaluating Concomitant Administration of VAX-31 and a Seasonal Influenza Vaccine in First Half of 2027 ...

Last month, cases of flu reached their highest levels in the United States in 25 years. Many hospitals were unprepared for ...